Quest Diagnostics (DGX) Divestments (2013 - 2016)

Quest Diagnostics (DGX) posted Divestments of $25.0 million for Q4 2016, up 600.0% sequentially from -$5.0 million in Q3 2016.

Quest Diagnostics (DGX) Divestments (2013 - 2016) Analysis & Trends

Quest Diagnostics (DGX) has 2 years of Divestments data on file, last reported at $25.0 million in Q4 2016.

Quarterly Divestments changed N/A year-over-year to $25.0 million in Q4 2016, while the trailing twelve-month figure through Sep 2020 was $25.0 million (changed N/A YoY) and the FY2021 annual result came in at $755.0 million, changed N/A from the prior year.
Divestments rose to $25.0 million in Q4 2016 per DGX's latest filing, from -$5.0 million in the prior quarter.
The five-year high for Divestments was $30.0 million in Q3 2013, with the low at -$5.0 million in Q3 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	-
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	-
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	-
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	-
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	-
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	-
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	-
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	-
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	-
10	Quest Diagnostics	23.76 Bn	23.67 Bn	942.00 Mn	-

Download Data